Trevi Therapeutics, Inc.

NasdaqGM:TRVI Stock Report

Market Cap: US$224.4m

Trevi Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Trevi Therapeutics has a total shareholder equity of $59.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $68.9M and $9.9M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$65.49m
EquityUS$58.97m
Total liabilitiesUS$9.94m
Total assetsUS$68.91m

Recent financial health updates

Recent updates

We Think Trevi Therapeutics (NASDAQ:TRVI) Can Afford To Drive Business Growth

Sep 27
We Think Trevi Therapeutics (NASDAQ:TRVI) Can Afford To Drive Business Growth

We Think Trevi Therapeutics (NASDAQ:TRVI) Can Afford To Drive Business Growth

May 24
We Think Trevi Therapeutics (NASDAQ:TRVI) Can Afford To Drive Business Growth

Trevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth Plans

Jan 27
Trevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth Plans

Trevi adds 19% on full data set from mid-stage cough study

Sep 19

Trevi Therapeutics: Moving Forward

Sep 11

Is Trevi Therapeutics (NASDAQ:TRVI) Using Too Much Debt?

Mar 23
Is Trevi Therapeutics (NASDAQ:TRVI) Using Too Much Debt?

Trevi has a new development chief

Feb 01

Financial Position Analysis

Short Term Liabilities: TRVI's short term assets ($67.3M) exceed its short term liabilities ($9.1M).

Long Term Liabilities: TRVI's short term assets ($67.3M) exceed its long term liabilities ($816.0K).


Debt to Equity History and Analysis

Debt Level: TRVI is debt free.

Reducing Debt: TRVI had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TRVI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: TRVI has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 9.5% each year.


Discover healthy companies